Down-regulation of argininosuccinate synthetase is associated with cisplatin resistance in hepatocellular carcinoma cell lines: implications for PEGylated arginine deiminase combination therapyJennifer A McAlpine, James A. Thomson, Susan K. Knowles et al.|BMC Cancer|2014Cited by 65
PEGylated arginine deiminase can modulate tumor immune microenvironment by affecting immune checkpoint expression, decreasing regulatory T cell accumulation and inducing tumor T cell infiltrationElena Brin, Wei He, Katherine Wu et al.|Oncotarget|2017Cited by 54